Britannia Pharmaceuticals Ltd.
Edit Page
Report
Scan day: 05 February 2014 UTC
22
Virus safety - good
Description: Manufactures products for small patient populations including opiate detoxification, parkinsons disease, Infant Respiratory Distress Syndrome, asthma and serous otitis media. Site also provides patient information to several medications.
Britannia Pharmaceuticals Limited New International Marketing Director for Britannia Pharmaceuticals Britannia Pharmaceuticals (part of the STADA Arzneimittel group of companies) has appointed Robert Wood as Marketing Director, for international markets.
Size: 254 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Britannia Pharmaceuticals Limited |
| Keywords: | britannia pharmaceuticals, apo-go, apomorphine, parkinson's disease, britaject, britlofex, lofexidine, opiate detoxification, crystapen, bacterial meningitis, benzylpenicillin, adsurf, surgical adhesions, pumactant, asthma, respiratory disease, dihydroergotamine, migraine, pantothenate, joint pain, lyonase, nasal drug delivery, pumactive, pulmonary drug delivery, male erectile dysfunction, UK, England, niche, Newbury, specialist |
| Description: | Britannia Pharmaceuticals Limited - pharmaceutical products for niche medical conditions |
| IP-address: | 46.38.174.100 |
WHOIS Info
| NS | Name servers: dns1.stabletransit.com dns2.stabletransit.com |
| WHOIS | |
| Date | Last updated: 29-Jun-2012 Expiry date: 29-Jul-2014 |